Literature DB >> 6809197

Fatal pulmonary fibrosis occurring during treatment with cyclophosphamide.

D A Burke, J C Stoddart, M K Ward, C G Simpson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809197      PMCID: PMC1499897          DOI: 10.1136/bmj.285.6343.696

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Early-onset cyclophosphamide-induced interstitial pneumonitis.

Authors:  J I Spector; H Zimbler; J S Ross
Journal:  JAMA       Date:  1979-12-28       Impact factor: 56.272

2.  Pulmonary toxicity of antineoplastic drugs.

Authors:  G Batist; J L Andrews
Journal:  JAMA       Date:  1981-09-25       Impact factor: 56.272

3.  Cyclophosphamide therapy and interstitial pulmonary fibrosis.

Authors:  A R Patel; P C Shah; H L Rhee; H Sassoon; K P Rao
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

  3 in total
  4 in total

Review 1.  Cyclophosphamide toxicity. Characterising and avoiding the problem.

Authors:  L H Fraiser; S Kanekal; J P Kehrer
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Diagnosis by bronchoalveolar lavage of cause of pulmonary infiltrates in haematological malignancies.

Authors:  G M Akoun; B J Milleron; C M Mayaud
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

Review 3.  Complications of cyclophosphamide therapy.

Authors:  C A Langford
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Acute respiratory failure during first cyclophosphamide infusion in a patient with systemic lupus erythematosus.

Authors:  P Schjelderup; T C El-Galaly; J B Frøkjær; T Ring
Journal:  Z Rheumatol       Date:  2014-12       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.